iTeos Therapeutics, Inc. (ITOS)

Last Closing Price: 10.02 (2025-05-30)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

iTeos Therapeutics, Inc. (ITOS) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-34.61M
Cost of Goods Sold
--
--
$40.02M
$-40.02M
$6.51M
$-33.51M
$-33.51M
$-34.61M
$-34.61M
$-34.61M
$-34.61M
$-40.02M
$-42.16M
43.24M
43.24M
$-0.80
$-0.80
Balance Sheet Financials
$537.04M
$5.05M
$121.83M
$658.87M
$38.00M
--
$57.45M
$95.45M
$563.42M
$563.42M
$563.42M
38.27M
Cash Flow Statement Financials
$-33.76M
$47.69M
$0.03M
$142.43M
$156.85M
$14.42M
$6.63M
--
--
Fundamental Metrics & Ratios
14.13
--
--
--
--
--
--
--
--
--
--
$-33.87M
--
--
--
--
--
--
--
-6.14%
-6.14%
-5.25%
-6.14%
$14.72
$-0.78
$-0.78